Epoch Biodesign
Epoch Biodesign
Agent34Agent Readiness: 34/100. Below median. Measured by StartupHub.ai. Median 41.Epoch Biodesign uses enzymes to break down plastic waste into monomers for new plastic production.
About
Epoch Biodesign is a biotechnology company focused on developing enzymatic solutions for plastic recycling. Their technology utilizes engineered enzymes to depolymerize plastic waste into its constituent monomers, which can then be used to create virgin-quality new plastics. This approach offers a more sustainable and circular method for managing plastic waste compared to traditional recycling or disposal methods.
Key facts
At-a-glance profile data
- Website
- epochbiodesign.com
- Headquarters
- Cambridge, Massachusetts, United States
- Founded
- 2021
- Total funding
- $12M (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 25 Mar 2026 | Funding Round | $12M | - |
Tech stack
Detected on epochbiodesign.com, last scanned 24 Sept 2026. Run your own scan
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
- Video / media
- Vimeo
Add first review
Frequently asked
How much funding has Epoch Biodesign raised?
Epoch Biodesign has raised a total of $12M in funding. The most recent round on record is Funding Round.